Not a good buy right now for an impatient investor: the stock just broke higher and is short-term extended/overbought near resistance.
Upside to consensus targets exists (many $20–$21 PTs vs ~$19), but near-term risk/reward is skewed to a pullback after the recent run.
Options sentiment is bullish, but recent Congress selling and EPS/net income YoY declines reduce conviction to chase at today’s level.
Best stance now: Hold / avoid chasing; a materially better buy would be on a dip closer to prior breakout/support (~$18 area).
Technical Analysis
Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, confirming an established uptrend.
Momentum: MACD histogram positive and expanding (0.0729) → buyers still in control.
Stretch/Overbought: RSI(6) ~77.9 → overheated short-term, higher odds of consolidation/pullback.
Levels: Pivot ~17.90; Resistance R2 ~19.37 (price ~19.06 is approaching this zone). A clean break above ~19.37 would be the next technical confirmation, but current positioning is late for an impatient entry.
Pattern-based forward view provided: probabilities lean slightly negative over 1W/1M (next week -2.89%, next month -3.15%), reinforcing “don’t chase today.”
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Put-call ratios are low (bullish/long-biased) → traders are leaning constructive.
Liquidity/Activity: Today’s option volume ~3,843 vs 30D average ~90.6% → activity is healthy but not a blow-off.
Volatility: IV30 ~28.1 vs HV ~31.4 → IV slightly below realized; not showing panic hedging.
Takeaway: Options market looks supportive, but it doesn’t offset the fact the stock is technically stretched near resistance today.
Technical Summary
Sell
4
Buy
11
Positive Catalysts
Cadence Bank merger completion (Feb 2): added scale in Texas/Southeast; branch/network expansion and potential revenue synergies.
Analyst catalysts: Morgan Stanley named HBAN a Top Pick among midcap banks; multiple firms highlight paths to ~$2 EPS by 2027 via synergies, expense control, and buybacks.
Wall Street pros: synergy paths, scale benefits, buyback potential.
Wall Street cons: expense outlook/integration friction and credit risk as wildcard.
Wall Street analysts forecast HBAN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HBAN is 20.23 USD with a low forecast of 16 USD and a high forecast of 23 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast HBAN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HBAN is 20.23 USD with a low forecast of 16 USD and a high forecast of 23 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Buy
2 Hold
1 Sell
Moderate Buy
Current: 19.020
Low
16
Averages
20.23
High
23
Current: 19.020
Low
16
Averages
20.23
High
23
UBS
Buy
to
Buy
downgrade
$22 -> $21
AI Analysis
2026-02-04
New
Reason
UBS
Price Target
$22 -> $21
AI Analysis
2026-02-04
New
downgrade
Buy
to
Buy
Reason
UBS lowered the firm's price target on Huntington Bancshares to $21 from $22 and keeps a Buy rating on the shares.
Morgan Stanley
Manan Gosalia
Overweight
upgrade
$21
2026-02-04
New
Reason
Morgan Stanley
Manan Gosalia
Price Target
$21
2026-02-04
New
upgrade
Overweight
Reason
Morgan Stanley analyst Manan Gosalia is moving Huntington Bancshares (HBAN) to Top Pick among midcap banks, replacing Valley National (VLY), telling investors that the firm sees multiple paths for the bank to get to about $2 in EPS by 2027. These include achieving deal-related revenue synergies, lower expense growth, and higher buybacks, notes the analyst, who has an Overweight rating and $21 price target on Huntington shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HBAN